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Introduction
The semaphorins are one of the largest families of guidance 
molecules, and include eight distinct classes. Some semaphorins 
are secreted molecules capable of long-range diffusion, whereas 
others  are  membrane-bound  proteins  that  function  as  short-
range guidance cues (Tran et al., 2007). Initially discovered as 
axon-guidance molecules, semaphorins also have much broader 
biological functions: they are now known to be involved in cell 
migration, synapse formation, and dendrite development, as well 
as immune and respiratory system function, vascular develop-
ment, and tumor angiogenesis (Tran et al., 2007; Neufeld and 
Kessler, 2008). However, how different cells translate extracel-
lular semaphorin ligand binding into intracellular signaling and 
cytoskeletal changes, thereby affecting diverse biological func-
tions, is still not fully understood.
Semaphorins signal primarily through multimeric receptor 
complexes in which plexins (A–D), a family of large transmem-
brane proteins, serve as the major signaling receptor compo-
nents. Secreted class 3 semaphorins generally signal through a 
holoreceptor composed of the ligand-binding subunit Neuropilin 
(Npn) and the signal transducing subunit PlexinA (Tran et al., 
2007). The only known exception is the secreted Semaphorin 
3E (Sema3E), which binds directly to PlexinD1 and is not   
dependent on Npn for binding (Gu et al., 2005). In contrast   
to secreted semaphorins, many membrane-bound semaphorins 
appear to require only plexins for signaling. So far, our limited 
understanding of downstream plexin signaling stems mainly 
from cell culture data and Drosophila melanogaster models. 
Studies in neurons have revealed that semaphorin binding on 
the cell surface triggers the depolymerization and redistribution 
of F-actin filaments. This reorganization causes filopodia and 
lamellipodia to retract, and ultimately leads to growth cone col-
lapse. The only direct link between plexin signaling and changes 
in the actin cytoskeleton is the actin-binding flavoprotein mono-
oxygenase MICAL (molecule interacting with CasL), which was 
identified from a Drosophila genetic screen and characterized 
in invertebrates (Hung et al., 2010).
In contrast to plexin signaling in invertebrate systems, our 
understanding of how semaphorin–plexin signaling is trans-
duced in the vertebrate system remains elusive. Most vertebrate   
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xtracellular  signals  have  to  be  precisely  inter-
preted intracellularly and translated into diverse 
cellular behaviors often mediated by cytoskeletal 
changes. Semaphorins are one of the largest families   
of guidance cues and play a critical role in many sys-
tems. However, how different cell types translate extra-
cellular  semaphorin  binding  into  intracellular  signaling 
remains unclear. Here we developed and performed a 
novel image-based genome-wide functional RNAi screen 
for downstream signaling molecules that convert the inter-
action between Semaphorin 3E (Sema3E) and PlexinD1 
into cellular behaviors. One of the genes identified in this 
screen is a RhoGAP protein, SH3-domain binding pro-
tein 1 (SH3BP1). We demonstrate that SH3BP1 mediates 
Sema3E-induced  cell  collapse  through  interaction  with 
PlexinD1 and regulation of Ras-related C3 botulinum toxin 
substrate 1 (Rac1) activity. The identification and charac-
terization of SH3BP1 as a novel downstream effector of 
Sema3E-PlexinD1 provides an explanation for how ex-
tracellular signals are translated into cytoskeletal changes 
and unique cell behavior, but also lays the foundation for 
characterizing other genes identified from our screen to 
obtain a more complete picture of plexin signaling.
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characterization of SH3BP1 as a novel downstream effector 
mediating Sema3E-PlexinD1 signaling provides an explanation 
for how extracellular signals are translated into intracellular   
cytoskeletal changes.
Results
Functional identification of Sema3E-
PlexinD1 downstream signalling  
molecules using an unbiased image-based 
genome-wide RNAi screen
Previously, we have shown that Sema3E-PlexinD1 is required 
for vascular patterning in vivo (Gu et al., 2005; Kim et al., 
2011). However, the intracellular signaling pathways that trans-
duce PlexinD1 activity in ECs remain unclear. To identify pro-
teins required for Sema3E-PlexinD1 signaling, we established 
an unbiased and robust cell-based assay. We first searched for   
a cell line that endogenously expresses PlexinD1 and shows a 
clear and measurable visual response to Sema3E. We and others 
(Casazza et al., 2010; Sakurai et al., 2010) have discovered that 
human umbilical vein ECs (HUVECs) endogenously express 
PlexinD1 (Fig. S1 A) and respond to Sema3E treatment inde-
pendent of substrate context (the response is reproducible when 
cells are grown on glass, plastic, or collagen; unpublished data). 
When treated with Sema3E, HUVECs undergo rapid morpho-
logical changes that lead to a complete collapse of the cytoskel-
eton within 25 min at 37°C, a significant reduction in cell surface 
area, and the formation of distinct membrane protrusions (Fig. 1, 
A and C). We performed an image-based RNAi screen of the 
human genome using this robust Sema3E-induced HUVEC col-
lapse assay to identify intracellular signal transduction components 
of Sema3E-PlexinD1 (Fig. 1 B). The hits identified from this 
functional screen are most likely involved in Sema3E-PlexinD1 
signaling in vivo.
To perform a large-scale genome-wide screen using cell 
collapse as a readout, we then developed an automated image 
analysis algorithm to enable fast and unbiased identification of 
the collapse response at single-cell resolution. The collapse cri-
teria were established based on images from the control condi-
tions (Fig. 1 C). Specifically, the identification of a collapsed   
cell was performed based on the cell area and then the pres-
ence of protrusions on the cell surface (Fig. 2, A–D). Cells with 
an area <700 arbitrary units (au) were classified as collapsed, 
and cells with area >1,000 au were classified as noncollapsed.   
To systematically categorize the population of cells with an 
area between 700 au and 1,000 au, we looked at the presence/
absence of protrusions on the cell surface, and classified any cell 
with at least one protrusion as collapsed. Using the algorithm 
that we developed based on these criteria, HUVECs trans-
fected with a nontargeting siRNA (negative control) showed a 
mean of 72% collapse, whereas PlexinD1 siRNA-transfected 
cells (positive control) displayed 25% collapse after treatment 
with Sema3E (Fig. 1 D). We defined strong hits as siRNAs 
that reduced the percentage of cell collapse >3 SDs from the 
mean of the plate-matched negative controls (nontargeting 
siRNA-transfected  wells)  and  <3  SDs  from  plate-matched 
positive controls (PlexinD1 siRNA-transfected wells; Fig. 2 E). 
plexin signaling studies to date have used a candidate ap-
proach based upon plexins’ putative endogenous R-Ras GTPase-
activating protein (GAP) domain (Oinuma et al., 2004a, 2006; 
Toyofuku et al., 2005; Ito et al., 2006; Gelfand et al., 2009). The 
intracellular domain of all plexins shares homology with GAPs, 
and in vitro studies using both cell-based experiments and puri-
fied proteins showed that this GAP activity leads to the deacti-
vation of R-Ras, M-Ras, and Rap1 (Rohm et al., 2000; Oinuma 
et al., 2004a,b; Toyofuku et al., 2005; Saito et al., 2009; Uesugi 
et al., 2009; Wang et al., 2012). However, identifying a specific 
small GTPase as the effector for the individual plexin-mediated 
signaling has been controversial. For example, plexin-mediated   
deactivation of R-Ras (Oinuma et al., 2004b), activation of RhoA 
(Swiercz et al., 2002, 2009), and deactivation of Rap1 (Wang 
et al., 2012) have all been implicated as the underlying cause   
of axonal growth cone collapse of primary neurons. So far, whether 
loss of Ras-GAP activity in vivo is required for plexin-mediated 
biological processes has not been tested. Therefore, an unbiased   
approach to identify vertebrate semaphorin–plexin signaling com-
ponents is necessary to fully understand how cells translate 
extracellular semaphorin binding to intracellular signaling and 
cytoskeletal changes.
Previously, we identified Sema3E and PlexinD1 as a novel 
ligand–receptor pair and demonstrated their in vivo requirement 
for heart and vascular patterning (Gu et al., 2005; Kim et al., 
2011), as well as neural circuit development (Ding et al., 2012). 
PlexinD1 is expressed exclusively in endothelial cells (ECs) 
during early embryonic development, and somatic expression 
of Sema3E controls intersomitic vessel patterning via repulsive 
signaling through the PlexinD1 receptor (Van Der Zwaag et al., 
2002; Gitler et al., 2004; Torres-Vázquez et al., 2004; Gu et al., 
2005). Sema3E-PlexinD1 signaling is also required for the ini-
tial development of descending axon tracts in the mouse fore-
brain in vivo (Chauvet et al., 2007). Sema3E-PlexinD1 activity 
has been shown to be required for thymocyte migration in the 
developing immune system in an Npn1-independent manner 
(Choi et al., 2008). In addition, Sema3E-PlexinD1 signaling has   
been implicated in tumor angiogenesis and metastases (Roodink 
et al., 2005, 2008; Kigel et al., 2008). However, the downstream 
signaling components of PlexinD1 are still largely unknown. 
Therefore, identification of the Sema3E-PlexinD1 downstream 
signaling  cascade  is  critical  for  understanding  how  it  could 
elicit these diverse responses in different systems.
In this study, we performed an unbiased functional image-
based genome-wide RNAi screen to identify downstream sig-
naling molecules required for Sema3E-PlexinD1 signaling. This 
screen yielded several candidate genes that belong to different 
cellular processes. Here, we focused on one of the genes identi-
fied from the screen, a Rho-GAP protein, SH3-domain bind-
ing protein 1 (SH3BP1). We demonstrate that Sema3E-PlexinD1 
signaling regulates cytoskeleton changes by down-regulation of 
Ras-related C3 botulinum toxin substrate 1 (Rac1) activity, which 
is mediated by SH3BP1. Moreover, SH3BP1 is colocalized 
with PlexinD1 at the lamellipodia, and its activity is regulated 
by Sema3E-PlexinD1 binding. Finally, we also demonstrated 
that SH3BP1 is required for the repulsive guidance effect of 
Sema3E-PlexinD1 on EC migration. The identification and 575 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
were fixed, stained with DiI and DAPI, and imaged. On each 
plate, PlexinD1 siRNA was used as a positive control to en-
sure that the collapse was efficiently blocked, and nontarget-
ing siRNA was used as a negative control (Fig. S1 B). Of the 
total 21,121 genes screened, knockdown of 384 (1.8%) genes 
displayed significant reduction in cell collapse comparable to 
PlexinD1 siRNA knockdown (Fig. 1, C and D). To validate 
these hits, we performed a secondary screen in which four 
siRNA duplexes of the hits were individually tested. Of the 
384 genes tested in our secondary screen, 233 (60.7%) were 
validated  by  at  least  two  out  of  four  individual  duplexes.   
We categorized the reconfirmed genes from our screen into 
several groups including transcription and translation factors, 
Wells that were >3 SDs from both positive and negative con-
trol means were designated weak hits and were examined by 
manual observation. After automated imaging, the percentage 
of HUVECs collapsed was computed from each well and ana-
lyzed by these criteria.
HUVECs were plated in a 384-well plate (Fig. S1 B) and 
then transfected with 50 nM of siRNA targeting each gene in 
the human genome from a commercially available Dharmacon 
library of siRNA smart pools (four unique duplexes targeting 
different regions of the same mRNA) and incubated for 48 h to 
allow for significant protein knockdown (Fig. 1, A and B). 
Cells were then treated with 2 nM Sema3E or vehicle control 
at 37°C and 5% CO2 for 25 min. After ligand treatment, cells 
Figure 1.  An image-based genome-wide screen to unbiasedly identify Sema3E-PlexinD1 downstream signaling molecules. (A) Schematic illustration of the 
screen strategy. HUVECs endogenously express PlexinD1 and undergo cell collapse after Sema3E treatment. The RNAi screen identified genes that, when 
knocked down, block the Sema3E-induced cell collapse. (B) Schematic illustration of the automated screen procedure. Cells were transfected with smart 
pools of siRNA (four different sequence targets for each gene) for each well of the 384-well plates, and after 48 h Sema3E was added to the culture media   
for 25 min. Cells were fixed, stained, and imaged, and the cell collapse phenotype was quantified using the combination of CellProfiler and our custom- 
developed image analysis algorithm. (C) Automated imaging of a positive control well (PlexinD1 siRNA-transfected) and a negative control well (nontargeting   
siRNA-transfected) for each 384-well screening plate (images were generated from the DiI channel). HUVECs were transfected with nontargeting siRNA 
or PlexinD1 siRNA and treated with control ligand or Sema3E. Sema3E caused cell collapse resulting in decreased surface area and the appearance of 
protrusions (arrows). These cytoskeletal changes were completely blocked by PlexinD1 siRNA. Bar, 100 µm. (D) Quantification of cell collapse. Unlike cells 
treated with the control ligand, cells stimulated with Sema3E underwent cytoskeletal collapse, which was significantly blocked when PlexinD1 siRNA was 
used. Error bars indicate SD. *, P < 0.01. Control nontargeting siRNA did not alter the cellular response elicited by Sema3E.JCB • VOLUME 205 • NUMBER 4 • 2014   576
kinases, and proteins known to be required for cytoskeletal reg-
ulation, cell division, endocytosis, protein trafficking, and other 
basic cell biological processes (Table S2).
SH3BP1 was identified from the screen as 
a candidate effector of Sema3E-PlexinD1 
signaling, and further validated by  
siRNA-resistant SH3BP1 rescue and 
PlexinD1/SH3BP1 colocalization
Of  the  233  strong  candidates  identified  from  our  secondary 
screen, SH3BP1, a GAP, has been further examined because of 
the role of GAP family proteins in regulation of small GTPases 
that control actin cytoskeleton dynamics. Many GAPs or regu-
latory proteins, such as IQGAP3, ARHGAP1, and RabGAP1, 
were negative hits in our screen. From the positive hits, SH3BP1 
is one of the few known small GTPase regulatory proteins, down-
regulation of which leads to strong blockage of Sema3E-induced 
cell collapse. Therefore, SH3BP1 emerged as a specific and unique 
candidate. SH3BP1 is expressed in HUVECs and ECs isolated 
from lungs and brain of embryonic day 18.5 (E18.5) mouse 
embryos (Fig. S2, A and B). Knockdown of SH3BP1 in HUVECs 
showed strong inhibition of Sema3E-induced cell collapse 
(Fig. 3 A). As shown from the screen of automatic imaging and 
collapse analysis, SH3BP1 knockdown led to a significant de-
crease in the percentage of the collapsed cells compared with 
negative control cells (35% vs. 70%, respectively; Fig. 3 B),   
a degree that is similar to that of PlexinD1 knockdown (Fig. 3, 
A and B).
The first criterion we used to validate strong hits from our 
screen was to examine their protein localization, reasoning that 
a downstream effector should colocalize with PlexinD1 in the 
same subcellular compartment. To examine whether PlexinD1 
and SH3BP1 colocalize, HUVECs transfected with PlexinD1-
GFP and SH3BP1-HA were immunostained using GFP and HA 
Figure  2.  Automated  image  analysis  of 
HUVEC morphology and Sema3E-induced cell 
collapse.  (A)  Raw  images  of  cells  acquired 
from a well of a screening plate by automated 
microscopy. DiI labeling combined with image 
analysis algorithms enabled automated quan-
tification  of  cellular  morphological  changes 
at the screening end point. (B) Cellular mem-
brane boundaries were overlaid on top of the 
raw image so that cell surface area could be 
automatically measured. (C) Cell protrusions 
were labeled in blue on top of the segmented 
cell masks so that the number of protrusions 
per cell could be counted. The green regions 
were the bumps on the cell surface that were 
too short to be classified as protrusions. Bar, 
100 µm. (D) Physical parameters used to clas-
sify collapsed cells were determined based on 
the cell surface area distribution from the con-
trol wells (top, histogram) in combination with 
cell protrusion counts. Cells were classified as 
collapsed based on a reduction in their sur-
face area and/or the presence of protrusions.   
(E)  siRNAs  that  blocked  Sema3E-induced 
HUVEC collapse were classified as strong hits 
if the percentage of cells collapsed was 3 SDs 
away from the plate-matched negative controls 
and within 3 SDs of the plate-matched positive 
controls  (PlexinD1  siRNA;  red  box).  siRNAs 
that partially blocked collapse were classified 
as weak hits (blue box).577 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
Figure 3.  SH3BP1 was identified from the screen as a downstream component of Sema3E-PlexinD1 signaling, and further validated by siRNA-resistant 
SH3BP1 rescue and PlexinD1/SH3BP1 colocalization. (A) Automated image acquisition showed that SH3BP1 knockdown blocked Sema3E-induced col-
lapse to similar extent as PlexinD1 siRNA. HUVECs treated with Sema3E underwent cell collapse that was inhibited by transfection with siRNA targeted 
specifically to PlexinD1 or SH3BP1. Bar, 100 µm. (B) Quantification of the Sema3E-induced cell collapse using the automated image analysis algorithm. 
***, P < 0.0001. Error bars indicate SEM. (C) PlexinD1 and SH3BP1 colocalized at the leading edge of the cell (arrows). PlexinD1-GFP and SH3BP1-
HA were coexpressed in HUVECs and stained with the corresponding antibodies. Bar, 10 µm. (D) Endogenous localization of PlexinD1 and SH3BP1 
in HUVECs. PlexinD1 and SH3BP1 colocalized in the leading edge of the cells (arrows). The boxed regions are enlarged on the right. Bar, 10 µm.   
(E) Reintroducing SH3BP1 protein rescued SH3BP1 siRNA inhibition of Sema3E-induced collapse. HUVECs were transfected with SH3BP1 siRNA followed 
by transfection with control DNA or the siRNA-resistant SH3BP1 construct and treated with Sema3E or control ligand. Strong cell collapse was observed 
only in cells transfected with the rescue construct (arrows). Cell shape was visualized by DTAF labeling (green) and vector expression was detected by an 
HA antibody (red). Bar, 100 µm. (F) Quantification of the cell collapse demonstrated the ability of the siRNA-resistant SH3BP1 to fully rescue the Sema3E-
induced collapse. **, P < 0.001. Error bars indicate SEM.JCB • VOLUME 205 • NUMBER 4 • 2014   578
antibodies, respectively. Interestingly, PlexinD1 protein was not 
uniformly expressed on the cell membrane; instead, it was 
highly enriched at the leading edge of the cell (Fig. 3 C). Con-
sistent with previous reports (Parrini et al., 2011), we found a 
similar pattern of SH3BP1 localization (Fig. 3 C). Moreover, 
we investigated the localization of endogenous PlexinD1 and   
SH3BP1 in HUVECs using specific antibodies. Endogenous 
PlexinD1 and SH3BP1 localized in the same pattern as observed 
in overexpression experiments (Fig. 3 D and Fig. S2 C). These 
data further support the hypothesis that SH3BP1 functions down-
stream of Sema3E-PlexinD1 signaling. Interestingly, some of the 
strong hits from our screen, which are also small GTPase regu-
latory proteins, failed to pass this criterion and therefore were 
not pursued further.
To further validate these results, we performed rescue 
experiments to demonstrate that SH3BP1 siRNA knockdown 
was specific to the designed target (Fig. S2, D and E). Specifi-
cally,  we  performed  rescue  experiments  by  cotransfecting   
HUVECs with a plasmid encoding mouse HA-tagged SH3BP1 
protein (rescue construct) containing five mismatches at the 
siRNA target site that rendered the gene resistant to siRNA 
knockdown. As shown in Fig. S2 D, Western blot analysis in-
dicated that the messenger RNA encoded by the rescue con-
struct was not knocked down by siRNA. In contrast, endogenous 
SH3BP1 was reproducibly and efficiently depleted by siRNA 
treatment. HUVECs were cotransfected with SH3BP1 or con-
trol siRNA with a rescue construct or control vector alone, 
respectively. 48 h after transfection, cells were treated with 
Sema3E or control alkaline phosphatase (AP) ligand, and cell 
collapse was analyzed. Sema3E-induced collapse was restored 
to normal levels when the SH3BP1-HA protein was reintro-
duced (Fig. 3, E and F), which demonstrates that SH3BP1 is 
required  for  Sema3E-PlexinD1–mediated  HUVEC  collapse. 
As expected, Sema3E induced strong collapse in cells trans-
fected with control siRNA and control vector alone. Cells 
transfected with SH3BP1 alone or together with control vector 
did not show cell collapse, whereas transfection of the siRNA 
together with siRNA-resistant SH3BP1-HA construct resulted 
in cell collapse after Sema3E treatment (Fig. 3, E and F). These 
experiments confirmed the specificity of the siRNAs and fur-
ther demonstrated that the loss of SH3BP1 function blocks 
Sema3E-PlexinD1 downstream signaling.
Dynamic changes of actin cytoskeleton 
during Sema3E-induced cell collapse  
are inhibited by PlexinD1 or  
SH3BP1 knockdown
To further validate SH3BP1 as a potential downstream effec-
tor of Sema3E-PlexinD1 signaling and determine the tempo-
ral and spatial effect of SH3BP1 loss of function on Sema3E- 
induced cell collapse, we examined the morphological changes 
of the cells that undergo collapse by time-lapse microscopy. 
Live imaging was performed on HUVECs transfected with 
control, PlexinD1, or SH3BP1 siRNA and stimulated with 
Sema3E. Treatment of HUVECs with Sema3E caused rapid 
membrane retraction, which was already obvious after 2.5 min, 
and a complete cell collapse within 20 min (Fig. 4 A and Video 1). 
Knockdown of PlexinD1 or SH3BP1 by siRNA resulted in 
maintenance of the EC’s shape long after exposure to Sema3E 
(Fig. 4 A, Video 2, and Video 3). Changes in cell size were quan-
tified for all three conditions at different time points and nor-
malized to time zero (Fig. 4 B). These experiments demonstrated 
that loss of SH3BP1 function blocked the cell collapse normally 
induced by Sema3E-PlexinD1 signaling.
To understand the effect of SH3BP1 on the underlying   
cytoskeleton during Sema3E-induced cell collapse, we used 
fluorophore-conjugated phalloidin to visualize the changes in 
F-actin organization. HUVECs transfected with control, PlexinD1, 
or SH3BP1 siRNA were treated with Sema3E for different 
durations of time followed by fixation and staining with phal-
loidin. HUVECs treated with Sema3E caused noticeable actin 
cytoskeleton changes as early as 2.5 min and a complete actin 
filament collapse by 20 min, a pattern similar to the one observed 
in live imaging (Fig. S3). This Sema3E effect was stronger at 
later time points, and therefore we analyzed the presence of la-
mellipodia and actin stress fibers at 10 and 20 min after ligand 
treatment. For example, at 10 min after Sema3E treatment, con-
trol siRNA-transfected cells appeared to lose their characteris-
tic shape as the F-actin network was disrupted and disorganized. 
In addition, cells displayed a perturbation in the linear arrange-
ment of F-actin stress fibers, and a perinuclear accumulation 
of stained actin was detected (Fig. 4, C and D). By 20 min 
after ligand exposure, most of the cells still showed strong   
cytoskeleton  collapse.  In  contrast,  PlexinD1  and  SH3BP1 
siRNA-transfected  cells  stimulated  with  Sema3E  retained 
their original size, maintained their organized network of lin-
ear F-actin stress fibers throughout the cytoplasm, and exhib-
ited strong actin staining at the cell membrane at every time 
point of Sema3E treatment (Fig. 4, C and D). These experi-
ments showed that Sema3E treatment leads to actin disorgani-
zation in ECs, which is blocked by the knockdown of PlexinD1 
and SH3BP1.
RNAi-mediated knockdown of Rac1  
causes hypercollapse of ECs, and  
constitutively active Rac1 blocks  
Sema3E-induced collapse
In our RNAi screen we examined genes that suppressed cell 
collapse as well as those that enhanced the Sema3E-induced 
collapse, reasoning that the latter might reveal proteins that 
were down-regulated in response to Sema3E-PlexinD1 activity. 
One such gene was Rac1, a member of the Rho superfamily of 
small GTPases. We found that siRNA duplexes against Rac1 
enhanced collapse in Sema3E-treated HUVECs (Fig. S4 A and 
Table S1). Rac1 is known to play a role in PlexinA1 and PlexinB1 
signaling, where it is down-regulated after ligand treatment   
(Gelfand et al., 2009). Consistent with this idea, we found that 
overexpressing a constitutively active Rac1 mutant protein 
(Rac1-Q61L) in HUVECs completely blocked Sema3E-induced   
collapse (Fig. 5 A). These data further support the possibility 
that Rac1 is also involved in the Sema3E-PlexinD1 signaling 
cascade. Given the knowledge from previous in vitro studies 
that SH3BP1 is a GTPase activating protein (GAP), acting 
specifically as a GAP for Rac1 (Cicchetti et al., 1992, 1995; 579 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
Figure 4.  Sema3E treatment causes dynamic changes in the actin cytoskeleton and cell collapse, which is inhibited by PlexinD1 or SH3BP1 knockdown.  
(A) Live cell imaging in control, PlexinD1, and SH3BP1 siRNA-transfected HUVECs after Sema3E treatment. Representative DIC images were taken from 
time-lapse videos of cells at different time points after Sema3E treatment. Control cells underwent obvious morphological changes and exhibited cell col-
lapse in response to Sema3E treatment, whereas PlexinD1- and SH3BP1-depleted cells did not display any changes (see Videos 1, 2, and 3 for the entire 
video sequence). (B) Quantification of live imaging. Cell size at different time points was measure and normalized to time point 0. **, P < 0.001. Error bars 
indicate SEM. (C) Actin staining in control, PlexinD1, or SH3BP1 siRNA–transfected HUVECs treated with Sema3E at different time points. Cells transfected 
with the corresponding siRNA were treated with Sema3E, fixed, and stained with phalloidin (green). In untreated cells, well-organized actin networks with 
lamellipodia and F-actin stress fibers were seen. After 10 and 20 min of exposure to Sema3E, control cells lost their shape and saw a disruption of F-actin 
stress fibers. Sema3E treatment of PlexinD1 and SH3BP1 siRNA–transfected cells exhibited an organized network with lamellipodia (yellow arrows) and 
F-actin stress fibers (white arrows) at every time point. Blue, DAPI. Bar, 10 µm. (D) Quantification of changes in the presence of lamellipodia and stress 
actin fibers upon Sema3E treatment. In control cells, the number of cells with lamellipodia and stress fibers was significantly reduced after 10 and 20 min 
of Sema3E treatment. PlexinD1- and SH3BP1-transfected cells did not show significant changes in the presence of lamellipodia and actin stress fibers at   
10 and 20 min from ligand introduction. n = 3. *, P < 0.01; **, P < 0.001. Error bars indicate SEM.JCB • VOLUME 205 • NUMBER 4 • 2014   580
Figure 5.  Sema3E-PlexinD1 signaling down-regulates Rac1 activity, which is medicated by SH3BP1 via its GAP activity. (A) Constitutively active Rac1 
blocks Sema3E-induced collapse. Cells were transfected with a constitutively active form of Rac1 (Rac1Q61L) and treated with control ligand or Sema3E. 
GFP construct was cotransfected to visualize cell morphology. While the addition of Sema3E to cells overexpressing only GFP led to strong cell collapse 581 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
(arrows), HUVECs transfected with Rac1Q61L were unable to undergo collapse after treatment with Sema3E. Bar, 100 µm. (B) PlexinD1 and SH3BP1 
colocalized with Rac1 at the lamellipodia (arrows) of HUVECs. PlexinD1-GFP and SH3BP1-HA were cotransfected in HUVECs and stained with GFP or HA 
antibodies combined with a Rac1 antibody. The boxed regions are enlarged on the right. Bar, 10 µm. (C) Sema3E induced a down-regulation of Rac1 
activity, which was blocked by PlexinD1 or SH3BP1 siRNA. HUVECs treated with Sema3E for 0, 2.5, 5, 10, or 20 min were lysed, precipitated with the 
PAK Rac1-binding domain, and blotted with a Rac1 antibody. Rac1-GTP, total Rac1, and Tubulin blots are shown. (D) Quantification of a Rac1 activity 
assay is shown. *, P < 0.05; **, P < 0.005. Error bars indicate SEM. (E) SH3BP1 GAP activity was required for Sema3E-induced collapse. Deletion of the 
GAP domain of SH3BP1 as well as the GAP activity–defective mutant failed to rescue SH3BP1 siRNA inhibition of Sema3E-induced collapse. Rescue ex-
periments with SH3BP1RhoGAP, SH3BP1-R232A, and SH3BP1-Res (full-length siRNA resistant) constructs are shown. Cell shape, DTAF labeling (green); 
vector expression, HA antibody (red). Arrows, cell collapse. Bar, 100 µm. (F) The results from D were quantified and the percentage of cell collapse is 
shown. ***, P < 0.01; n ≥ 3. Error bars indicate SEM. n.s., not significant.
 
Parrini et al., 2011), it is possible that the SH3BP1–Rac1 path-
way is downstream of Sema3E-PlexinD1 signaling to mediate 
cell collapse.
PlexinD1, SH3BP1, and Rac1 colocalize 
at the lamellipodia, and Sema3E induces 
down-regulation of Rac1 activity
Rac1 is involved in regulating the polymerization of actin at the 
leading edge, and is therefore localized in the cell lamellipodia 
(Hall, 1998; Ridley, 2001). We then examined whether PlexinD1, 
SH3BP1, and Rac1 colocalize in the leading edge of ECs. Cells 
transfected with PlexinD1-GFP or SH3BP1-HA followed by 
immunostaining with GFP or HA antibodies, respectively, in com-
bination with Rac1 antibody showed that PlexinD1 and SH3BP1 
colocalize with Rac1 in the leading edge of the cell, which sug-
gests that they may function in the same subcellular compart-
ment (Fig. 5 B).
Because of the general role of Rac1 in regulating cyto-
skeletal dynamics, its effects on Sema3E-induced cell collapse 
could be nonspecific. To directly test whether Sema3E treatment 
can specifically influence Rac1 activity, we performed an acti-
vated Rac1 pull-down assay. We lysed HUVECs after 0, 2.5, 5, 
10, and 20 min of Sema3E treatment and measured activated 
Rac1 by precipitating the lysates with beads conjugated to a 
GST-tagged PAK-RBD Rac1 binding domain (Rac1 binding do-
main of PAK protein) and blotting with Rac1 antibody. Rac1 ac-
tivity was down-regulated starting from 2.5 min after Sema3E 
treatment, and this down-regulation was completely blocked by 
PlexinD1 siRNA, which demonstrates that Sema3E-PlexinD1 
signaling specifically down-regulates Rac1 activity (Fig. 5,   
C and D). To understand how PlexinD1 down-regulates Rac1 
activity, we tested whether PlexinD1 (like PlexinA and -B) can 
directly bind to Rac1. Interestingly, in coimmunoprecipitation 
(coIP) experiments we did not observe a direct interaction be-
tween Rac1 and PlexinD1 at any time point either with or with-
out Sema3E treatment (unpublished data), which suggests that 
Sema3E-induced down-regulation of Rac1 activity may involve 
an indirect mechanism.
SH3BP1 mediates the Sema3E-induced 
down-regulation of Rac1 activity through 
its GAP domain
SH3BP1 contains three different domains with distinct func-
tions and controls cellular processes. Besides the GAP domain, 
the SH3 binding motif has been shown to interact with Abl ki-
nase (Cicchetti et al., 1992), whereas the F-BAR domain was 
implicated in membrane-remodeling processes and inhibits 
platelet-derived growth factor (PDGF)-induced membrane ruf-
fling in fibroblasts (Cicchetti et al., 1992, 1995; Dawson et al., 
2006; Heath and Insall, 2008). Therefore, together with our find-
ing that PlexinD1, SH3BP1, and Rac1 are colocalized in the same 
subcellular location, it is conceivable that SH3BP1 can function 
to mediate the Sema3E-PlexinD1–induced cell collapse via its 
GAP activity (Rac1 regulation) or its BAR domain function, or as 
an adaptor protein through its SH3-binding motif.
To test the hypothesis that Sema3E induces Rac1 activity 
through the SH3BP1, we knocked down SH3BP1 using specific   
siRNA. Similar to PlexinD1, SH3BP1 siRNA blocked the Sema3E-
induced down-regulation of Rac1 activity (Fig. 5, C and D). 
Therefore, SH3BP1 is upstream of Rac1, and Sema3E-PlexinD1 
signaling could regulate Rac1 activity through SH3BP1.
To test the importance of SH3BP1 GAP activity for Sema3E-
PlexinD1 signaling, we performed rescue experiments with an 
siRNA-resistant construct, SH3BP1RhoGAP (lacks the GAP 
domain). In addition, we also generated a more refined GAP   
activity–defective mutant carrying a single amino acid mutation. 
It has been shown that the arginine 312 in the GAP domain of 
human SH3BP1 is critical for its GAP activity. In particular, 
SH3BP1-depleted cells exhibited perturbations in Rac1 local-
ization, and the R312A SH3BP1 point mutation could not res-
cue this spatial defect (Parrini et al., 2011). We mutated the 
corresponding  arginine  (R312A)  in  the  mouse  SH3BP1  and 
generated SH3BP1-R232A mutant to check if this mutant is 
able to rescue the Sema3E-induced cell collapse. In SH3BP1 
siRNA-transfected HUVECs, the wild-type protein rescued cell 
collapse after Sema3E treatment, whereas the protein lacking 
the RhoGAP domain or the GAP-defective R232A mutant did 
not (Fig. 5, E and F). These data suggest that SH3BP1 may me-
diate Sema3E-induced down-regulation of Rac1 activity through 
its RhoGAP domain.
SH3BP1 forms a complex with PlexinD1 
via its BAR domain
We  hypothesize  that  Sema3E-PlexinD1  signaling  regulates 
Rac1 by activating SH3BP1, either directly or indirectly. Be-
cause SH3BP1 and PlexinD1 are colocalized in the lamellipo-
dia, we then tested whether they are associated in the same 
protein complex. To examine this, we performed coIP experi-
ments on cells that were either transfected with PlexinD1-GFP 
alone (negative control) or together with full-length SH3BP1-
HA construct (Fig. 6 A). Because of the low transfection effi-
ciency of the DNA construct in HUVECs, all coIP experiments 
were performed in transfected HEK293T cells. Cell lysates 
were  immunoprecipitated  with  GFP  antibody  followed  by   JCB • VOLUME 205 • NUMBER 4 • 2014   582
PlexinD1 (Fig. S5, A and B). Together, these data demonstrate 
that  the  BAR  domain  is  required  for  SH3BP1  association   
with PlexinD1.
Sema3E stimulation activates SH3BP1 in 
part by releasing it from PlexinD1
We next examined the effect of Sema3E treatment on the asso-
ciation between SH3BP1 and the PlexinD1 receptor complex. 
PlexinD1-GFP– and SH3BP1-HA–transfected HEK293T cells 
were treated with Sema3E for 0, 10, and 20 min followed by 
cell lysis and IP with GFP antibody. Immunoblot analysis with 
HA antibody showed that the interaction between PlexinD1 
and SH3BP1 was decreased after 20 min of Sema3E treatment 
(Fig. 6 C), which suggests that Sema3E binding to PlexinD1 re-
leased SH3BP1 from the receptor complex. We note that this is 
consistent with our observation in HEK293T cells, where Rac1 
immunoblotting with HA antibody. Full-length SH3BP1 was 
coimmunoprecipitated with PlexinD1-GFP (Fig. 6 B), which 
suggests that PlexinD1 and SH3BP1 are associated in a pro-
tein complex. To identify which domain of SH3BP1 mediates 
this association, we performed coIP experiments with PlexinD1-
GFP and either BAR or RhoGAP, or the SH3-binding motif 
deletion constructs SH3BP1BAR-HA, SH3BP1RhoGAP-HA, 
or SH3BP1SH3, respectively (Fig. 6 A). Although RhoGAP 
and SH3-binding motif deletions still resulted in coIP with 
PlexinD1, the BAR domain deletion abolished the association 
between PlexinD1 and SH3BP1 (Fig. 6 B), which demon-
strates that the BAR domain is required for this association. 
We next examined which of these three SH3BP1 domains are 
required for its colocalization with PlexinD1 in the lamelli-
podia. Consistent with the coIP result, full-length SH3BP1, 
SH3BP1GAP, and SH3BP1SH3 all colocalized with PlexinD1 
in lamellipodia, but SH3BP1BAR did not colocalize with 
Figure 6.  SH3BP1 forms a complex with Plex-
inD1 via its BAR domain, and Sema3E binding 
to PlexinD1 activates SH3BP1 by releasing it 
from the PlexinD1 complex. (A) Schematic il-
lustration of the SH3BP1 constructs used in this 
study. The full-length SH3BP1 construct contains 
BAR and RhoGAP domains and SH3 motifs on 
the  C-terminal  end.  In  the  SH3BP1RhoGAP   
construct, the GAP domain was deleted. The 
SH3BP1BAR construct lacked the BAR do-
main, and in the SH3BP1SH3 construct the 
SH3 motif was deleted. (B) SH3BP1 is associ-
ated with PlexinD1 through the SH3BP1 BAR 
domain.  HEK293T  cells  were  transfected 
with  PlexinD1-GFP  and  vectors  expressing 
SH3BP1 (SH3BP1-HA or deletion constructs 
SH3BP1BAR-HA, SH3BP1RhoGAP-HA, and 
SH3BP1SH3). Cells were lysed and immuno-
precipitated with a GFP antibody and immu-
noblotted with an HA antibody (right). PlexinD1 
and SH3BP1 expression levels in the cell lysates   
were determined by Western blotting with GFP 
and HA antibodies (left). (C) SH3BP1 dissoci-
ated from PlexinD1 upon Sema3E treatment. 
HEK293T cells transfected with PlexinD1-GFP 
and SH3BP1-HA were treated with Sema3E for 
0, 10, and 20 min, then lysed and immunopre-
cipitated with a GFP antibody and immunoblot-
ted with an HA antibody. The dissociation of 
SH3BP1 from PlexinD1 was observed 20 min 
after Sema3E treatment, as indicated on the 
right, while the protein expression levels are 
shown on the left.583 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
activity is significantly down-regulated 20 min after Sema3E 
treatment (Fig. S4 B). Taken together, these data suggest a model 
in which Sema3E stimulation releases SH3BP1 from PlexinD1 
and subsequently activates its GAP activity.
Releasing SH3BP1 from PlexinD1 is 
necessary but not sufficient for  
its activation
To test whether dissociating SH3BP1 from PlexinD1 is suf-
ficient to fully activate SH3BP1 and result in cell collapse, we 
first analyzed if overexpression of SH3BP1BAR will consti-
tutively activate SH3BP1 to recapitulate the cell collapse in-
duced by Sema3E ligand. SH3BP1 constructs were transfected 
in HUVECs and their morphology was analyzed. SH3BP1-, 
SH3BP1GAP-, and SH3BP1SH3-transfected cells showed 
normal cell morphology. However, 40% of the cells trans-
fected with SH3BP1BAR exhibited morphological changes 
similar to Sema3E-induced cell collapse (Fig. 7, A and B). 
This result indicates that although the release of SH3BP1 from 
PlexinD1 contributes to SH3BP1 activation, an additional sig-
nal is required to fully activate SH3BP1 function in mediating 
cell collapse.
To further understand the role of Sema3E-induced dis-
sociation of SH3BP1 from PlexinD1 and the requirement of 
the SH3BP1 BAR domain in Sema3E-induced cell collapse, 
we next performed rescue experiments with an siRNA-resistant 
SH3BP1BAR. As expected, with control ligand treatment, 
SH3BP1BAR exhibited 40% cell collapse, significantly 
higher than the control vector–transfected cells. Upon Sema3E 
treatment, the percentage of collapsed cells significantly in-
creased with SH3BP1BAR rescue (70%), equivalent to 
the level of rescue achieved by full-length SH3BP1 (Fig. 7, 
C and D). This suggests that the BAR domain of SH3BP1 is 
necessary but not sufficient for its function. It is conceivable 
that Sema3E treatment not only led to the release of SH3BP1 
from PlexinD1, but may have triggered a “second signal” that is 
needed to fully activate SH3BP1 and cause cell collapse.
Because the SH3-binding motif is known to mediate   
protein–protein interaction, we next examined whether the SH3-
binding motif of SH3BP1 plays any role in mediating the “second 
signal” required for Sema3E-induced cell collapse. We performed 
rescue experiments with siRNA-resistant SH3BP1SH3, but this 
construct successfully rescued cell collapse (Fig. 7, C and D), 
which suggests that the SH3-binding motif is not required for 
SH3BP1 function in the context of Sema3E-PlexinD1–mediated 
cell collapse.
Collectively, our findings demonstrate that in the absence 
of Sema3E, SH3BP1 is associated with the PlexinD1 receptor 
complex through the SH3BP1 BAR domain. This interaction 
allows the active form of Rac1 to control actin polymerization 
(Fig. 8 A). In the presence of Sema3E ligand, SH3BP1 dissoci-
ates from the PlexinD1 receptor complex, and achieves full 
activation by an unknown Sema3E-induced signal followed 
by inactivation of Rac1 through its RhoGAP activity, which 
in turn triggers actin cytoskeleton depolymerization and cell 
collapse (Fig. 8 B).
SH3BP1 is required for Sema3E-PlexinD1–
mediated EC repulsion
Previous in vivo and in vitro studies have demonstrated that a 
major function of Sema3E-PlexinD1 signaling in ECs is to serve 
as a repulsive signal to inhibit endothelial migration and vas-
cular sprouting (Gu et al., 2005; Kigel et al., 2008; Casazza   
et al., 2010; Fukushima et al., 2011). We used the well-established   
“repulsion” assay to study the function of SH3BP1 in Sema3E-
PlexinD1 signaling in a physiologically relevant context (Guttmann-
Raviv et al., 2007; Kigel et al., 2008; Bielenberg et al., 2008). 
As shown previously, Sema3E-expressing HEK293T cells re-
pelled ECs when seeded on top of a confluent monolayer of 
HUVECs, resulting in cell-free areas around the Sema3E- 
expressing cells (Fig. 9, A and B). In contrast, HEK239Ts ex-
pressing control ligand had no effect on the confluent monolayer   
of HUVECs. When HUVECs were transfected with PlexinD1 
or SH3BP1 siRNA, Sema3E-expressing HEK293T cells no 
longer had any effect on the HUVECs (Fig. 9, A and B). These 
data demonstrate that SH3BP1 is a key effector molecule re-
quired for the repulsive guidance effect of Sema3E-PlexinD1 
on EC migration.
Discussion
Here, we performed an image-based unbiased genome-wide RNAi 
screen to identify signaling molecules downstream of Sema3E-
PlexinD1. We subsequently characterized one of the genes 
identified from our screen, a Rho-GAP protein, SH3BP1. We first 
validated its functional requirement for Sema3E-PleixnD1–
mediated cell collapse by rescue experiments. We next demon-
strated that Sema3E-PlexinD1 down-regulates Rac1 activity, and 
that this down-regulation is mediated by SH3BP1. Moreover, we 
showed that, upon Sema3E binding, the prebound SH3BP1 disso-
ciates from the PlexinD1 complex and, through its GAP activity, 
converts Rac1-GTP to Rac1-GDP to initiate actin disassembly. 
Finally, SH3BP1 is required for Sema3E-PlexinD1–mediated EC 
repulsion. The identification and characterization of SH3BP1 as 
a novel downstream effector mediating Sema3E-PlexinD1 sig-
naling in ECs provides insights for how extracellular signals are 
translated into intracellular cytoskeletal changes and unique cell 
behavior. Moreover, this image-based approach can be applied to 
other ligand receptor–mediated signaling.
Inactivation  of  integrin  has  been  suggested  to  mediate 
Sema3E-induced cytoskeletal collapse (Sakurai et al., 2010). 
These authors showed that HUVECs or COS cells transfected 
with PlexinD1 collapsed in response to Sema3E only when the 
dishes were coated with integrin. In contrast, we performed our 
screening assay in HUVECs without any coating. This approach 
is substantiated by previous studies demonstrating that Sema3E 
still induces the rapid collapse of PlexinD1-transfected COS 
cells (Gu et al., 2005; Casazza et al., 2010) and suggests that 
Sema3E-PlexinD1 can initiate an intracellular signaling cas-
cade directly linked to actin depolarization and cell collapse. 
Moreover, the signaling molecules and pathway we discovered 
from our screen represent a direct mechanism, independent of 
the integrin pathway.JCB • VOLUME 205 • NUMBER 4 • 2014   584
Figure 7.  BAR domain deletion caused constitutive cell collapse, and Sema3E treatment enhanced the collapse. (A) Overexpression of SH3BP1BAR led 
to changes of cell morphology in HUVECs. SH3BP1-HA, SH3BP1GAP-HA, SH3BP1SH3-HA, and SH3BP1BAR-HA were overexpressed in HUVECs, 
and cells were stained with DTAF (green) and HA antibody (red). Deletion of the BAR domain caused changes in cell morphology and size compared with 
full-length SH3BP1 as well as GAP and SH3 deletion. Bar, 100 µm. (B) Quantification of overexpression experiments is shown. *, P < 0.01; n = 4. Error 
bars indicate SEM. (C) Deletion of the BAR domain of SH3BP1 partially rescued SH3BP1 siRNA inhibition of Sema3E-induced collapse. Rescue experiments 
with SH3BP1BAR, SH3BP1SH3, and SH3BP1-Res (full-length siRNA resistant) constructs are shown. Cell shape, DTAF (green); vector expression, HA 
antibody (red). Arrows, cell collapse. Bar, 100 µm. (D) The results from C were quantified and the percentage of cells collapsed is shown. *, P < 0.01; 
**, P < 0.001. n = 4. Error bars indicate SEM.585 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
Small  GTPases  and  their  regulators  (GEFs  and  GAPs) 
comprise a large portion of the genome, and regulation of their 
activities is a major mechanism underlying a vast range of bio-
logical activities. Emerging evidence demonstrates that specific 
members of the small GTPase superfamily mediate specific as-
pects of biological functions. For example, 2-chimaerin, a Rho 
GAP, has been shown to be essential for ephrin-mediated cortico-
spinal axon guidance in rodents (Beg et al., 2007; Iwasato et al., 
2007; Wegmeyer et al., 2007). A recent study also showed that the 
RacGAP 2-Chimaerin selectively mediates axonal pruning in 
the hippocampus (Riccomagno et al., 2012). Investigating the 
specific in vivo requirement of SH3BP1 in semaphorin-mediated 
neural and vascular development will be a future focus.
SH3BP1 is a relatively lesser known GAP protein. It was 
originally identified from an SH3 domain screening (Cicchetti 
and Baltimore, 1995). More recently, SH3BP1 has been shown 
to partner with an exocyst complex (Parrini et al., 2011) and 
mediate epithelial junction formation by regulating Cdc42   
activity (Elbediwy et al., 2012). Our results are the first study 
linking SH3BP1 to an external stimulus (Sema3E) through its 
interaction with the PlexinD1 receptor. The interaction of SH3BP 
with PlexinD1 through its BAR domain and the down-regulation 
of Rac1 through its GAP activity explain how Sema3E-PlexinD1 
signals are transmitted to ultimately produce intracellular cyto-
skeleton changes. Whether SH3BP1’s ability to regulate Cdc42, 
exocytosis, and junction formation plays any role in Sema3E-
PlexinD1 signaling will be investigated in the future.
We also identified several other candidate genes in our 
RNAi screen that might potentially be involved in Sema3E-
PlexinD1 signaling, and it will be interesting to examine how 
these genes might intersect with SH3BP1 signaling. For exam-
ple, our data so far suggest that dissociation of SH3BP1 from 
PlexinD1 contributes to the activation of its GAP activity, an-
other Sema3E-dependent signal that is also needed to fully acti-
vate SH3BP1. Such a signal could be one of the strong hits from 
our screen. It will be interesting to conduct similar screens at 
different time points using actin morphology as a readout to 
identify downstream molecules that act at different phases of 
Studies from PlexinA and -B families have implicated 
small GTPases as key molecules downstream of plexin signal-
ing. However, the specific mechanisms differ between PlexinA 
and -B (Negishi et al., 2005; Gelfand et al., 2009; Oh and   
Gu, 2013a). For example, Sema4D binding to PlexinB1 reduces 
Rac1 activity by binding to Rac1-GTP and thereby seques-
tering it from its downstream effector (Kruger et al., 2005), 
whereas Sema3A binding to PlexinA increases Rac1 activity by 
activating a Rac guanine exchange factor (Rac1GEF; Toyofuku 
et al., 2005). Interestingly, here we found that even the same 
ligand–receptor pair, Sema3E-PlexinD1, uses a different sig-
naling mechanism to regulate Rac1 GTPase activity from what 
was previously reported. Prior studies have suggested that, 
similar to the Sema4D–PlexinB1 pathway, PlexinD1 is in a 
conformation that enables its association with GTP-bound 
Rnd2 but prevents its interaction with GTP-bound Rac and R-Ras 
in the absence of Sema3E. Upon Sema3E binding, PlexinD1 
dissociates Rnd2 and binds the active forms of both Rac and 
R-Ras GTPases. As a result, Rac is sequestered, thereby in-
activating PAK and leading to the collapse of the actin-based 
cytoskeleton (Uesugi et al., 2009; Gay et al., 2011). However, 
here through an unbiased functional screen, we identified a 
RhoGAP protein, SH3BP1, as a novel key downstream signal-
ing molecule mediating Sema3E-induced down-regulation of 
active Rac1GTPase and actin cytoskeleton disassembly. Although 
the final outcome is the same (active Rac1 down-regulation and 
actin-based cytoskeleton collapse), one signaling pathway func-
tions by sequestering Rac1 and the other by activating SH3BP1 
to convert active Rac1-GTP to inactive Rac1-GDP. In addi-
tion, another study has suggested that the small GTPase RhoJ 
might be a mediator between Sema3E-PlexinD1 and VEGF-
VEGFR2 signaling through the regulation of GDP/GTP bind-
ing to RhoJ (Fukushima et al., 2011). Given the broad effect   
of Sema3E-PlexinD1 in diverse cell types, it is possible that 
the Rnd-mediated Rac1-sequesteration mechanism operates at 
times, while the SH3BP1 RhoGAP activity–mediated mecha-
nism functions at other times, depending on the cell type–specific 
expression of these effectors.
Figure 8.  A model of how SH3BP1–Rac1 mediates Sema3E-PlexinD1 regulation of cytoskeleton stability. (A) In the absence of Sema3E, SH3BP1 is associ-
ated with the PlexinD1 complex, and the active form of Rac1 (Rac1GTP) positively regulates actin polymerization. (B) Upon Sema3E treatment, SH3BP1 
dissociates from PlexinD1, becomes activated, and through its RhoGAP domain converts GTP-Rac1 to GDP-Rac1. The decreased Rac1 activity leads to 
actin depolymerization and cell collapse.JCB • VOLUME 205 • NUMBER 4 • 2014   586
a complete understanding of the signaling mechanisms result-
ing from these ligand receptor pairs will ultimately provide po-
tential therapeutic targets for diseases.
Materials and methods
Cell cultures
HEK293T cells were cultured in DMEM supplemented with 10% (vol/vol) 
FBS and 1% (vol/vol) penicillin/streptomycin. HUVECs were cultured in 
EGM-2 medium supplemented with a SingleQuots kit (Lonza). All cells 
were cultured in 5% CO2 at 37°C.
AP-tagged ligand production
HEK293T cells were transfected with AP-Sema3E or AP expression con-
structs using Lipofectamine 2000 (Invitrogen) according to the manufactur-
er’s instructions. Media was changed after 4 h. Cells were cultured for an 
the collapse. This unbiased functional screen will allow us to 
not only visualize a more complete picture of plexin signaling 
but also assemble the entire pathway to reveal the logical pro-
gression from signal integration, cytoskeleton regulation, and 
cellular behavior. We will also test whether the signaling path-
ways we have discovered are generally used by other plexins. It 
will also be important to examine whether the diverse functions 
of plexins in different cell types and processes are mediated   
by the same or distinct set of signaling mechanisms. In the long 
term, we hope to understand the overall properties of a signal-
ing network in neurons and ECs and to predict how this network 
will behave in response to new stimuli, or how it can be modi-
fied or rebuilt to give a desired effect. Finally, given the impor-
tant and diverse biological functions of semaphorins and plexins, 
Figure 9.  PlexinD1 and SH3BP1 play a role in Sema3E induced ECs repulsion. (A) HUVECs transfected with control, PlexinD1, and SH3BP1 siRNA were 
grown to a confluent monolayer. Cells were photographed 16 h later. HEK293T cells expressing control ligand or Sema3E were prelabeled with Hoechst 
33342 and added on top of HUVECs. HEK293T expressing Sema3E (arrows) were surrounded by a cell-free area, whereas HEK293T expressing a control 
ligand did not exhibit a cell-free area. PlexinD1 and SH3BP1 siRNA-transfected cells did not repel in the presence of a Sema3E source. Bright field and 
Hoechst 33342 channel are shown. Bar, 200 µm. (B) Quantification of cell free area surrounding HEK293T cells. *, P < 0.01; **, P < 0.001. n = 4. 
Error bars indicate SEM.587 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
Primary mouse EC isolation
Primary mouse ECs were isolated from mouse embryonic lungs and brain 
at E18.5 using a previously described protocol (Deng et al., 2013), with 
some modification. In brief, lungs and brain were dissected from embryos, 
minced finely with scissors, and then digested in 1 mg/ml Collagenase/
Dispase (Roche) for 45 min at 37°C on a rotator. The digested tissue sus-
pension was transferred to a syringe with a 14-g cannula attached, and 
clumps were triturated into a single cell suspension. Cells were centrifuged 
at 400 g for 5 min, then the pellet was resuspended in 0.1% BSA/PBS and 
incubated with anti–mouse CD31 (BD) antibody–coated Dynabeads (Invit-
rogen) at room temperature for 10 min with rotation. Using a magnetic 
separator, the bead-bound cells were washed with 0.1% BSA/PBS and re-
covered, then cultured in EGM-2 medium supplemented with a SingleQuots 
kit. The cells were then used for gene expression analysis by RT-PCR.
RNA isolation, cDNA synthesis, and RT-PCR
Total RNA was isolated using TRIzol (Invitrogen) according to the manufactur-
er’s protocol. Afterward, 1 µg of RNA from each sample was reverse tran-
scribed into cDNA using the SuperScript III Reverse transcription kit (Invitrogen). 
RT-PCR was performed with taq polymerase (QIAGEN) with the listed primers: 
GAPDH Fw, 5-GTCTACATGTTCCAGTATGACTCCACTCAC-3; GAPDH Rev, 
5-CAATCTTGAGTGAGTTGTCATATTTCTCGT-3; SH3BP1 Fw, 5-GCCCTC-
CATGATGTTTGC-3; and SH3BP1 Rev, 5-ACAGCCTCAGGGCCTTCT-3.
EC repulsion assay
HUVECs transfected with control, PlexinD1, or SH3BP1 siRNA were grown 
to confluence. HEK293T transfected with AP-Sema3E or AP were stained 
with NucBlue Live ReadyProbes Reagent (Invitrogen), then plated on top of 
the HUVECs and incubated for 16 h. The cells were then washed with PBS 
and fixed with 4% PFA for 15 min at room temperature, and washed in 
PBS. 10 randomly selected areas were imaged in PBS for each sample. 
Cell repulsion was quantified by calculating the cell free area using ImageJ 
software (National Institutes of Health). A minimum of 35 cell-free areas 
were measured and quantified for each condition.
CoIP
HEK293T cells were transfected with the indicated constructs using Lipo-
fectamine 2000 (Invitrogen) and grown in DMEM + 10% fetal bovine 
serum + 1% penicillin/streptomycin. 48 h after transfection, cells were 
washed rapidly with ice-cold PBS. Cells were lysed in lysis buffer (50 mM 
Tris/HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 2 mM EDTA, and   
2 mM DTT) containing complete proteinase inhibitors (Roche). After 30 min 
of rotation at 4°C and subsequent centrifugation, protein was quantified 
and 20 µg of protein was frozen down as input controls. 0.5 µg of rabbit 
anti-GFP antibody (Invitrogen) was added to 500 µg of protein and rotated 
at 4°C for 1 h. Then, 30 µl of Protein A/G beads (Thermo Fisher Scientific) 
were added to the protein and rotated overnight at 4°C. Beads were 
washed three times with lysis buffer and two times with wash buffer (lysis 
buffer with 300 mM NaCl). Protein was eluted by the addition of 2× SDS-
PAGE sample buffer and boiling for 10 min.
Western blotting
Protein samples were loaded on 8% or 12% polyacrylamide gels and run 
until  the  appropriate  protein  separation  was  achieved.  Samples  were 
transferred onto polyvinylidene difluoride (PVDF) membrane and blocked 
for 1 h in 5% nonfat milk in TBST (Tris-buffered saline + 0.1% Tween 20). 
The membranes were then incubated overnight (see next paragraph) with 
the following primary antibodies at 4°C: rabbit anti-GFP (Invitrogen), mouse 
anti-HA (Covance), mouse anti-Rac1 (BD), rabbit polyclonal antiserum 
raised against PlexinD1 peptide (CELVEPKKSHRQSHRKK; anti-PlexinD1 was 
a gift from Y. Yoshida, Cincinnati Children’s Hospital Medical Center, Cin-
cinnati, OH; Oh and Gu, 2013b), goat anti-SH3BP1 (Everest Biotech Ltd.; 
Parrini et al., 2011; Elbediwy et al., 2012), rabbit VE-Cadherin (Abcam), and 
mouse anti-Tubulin (Sigma-Aldrich). The intensity of individual bands was 
quantified using ImageJ.
Immunohistochemistry
HUVECs were grown on coverslips and then transfected with PlexinD1-GFP 
and/or SH3BP1-HA. After 48 h, cells were fixed in 4% PFA for 15 min, 
washed twice for 5 min in PBS, and permeabilized for 10 min in 1× PBT 
(1× PBS + 0.1% Triton X-100). The samples were then incubated for 1 h in 
10% donkey serum in PBT. After blocking, the samples were incubated with 
primary antibodies: rabbit anti-GFP (Invitrogen), mouse or rabbit anti-HA 
(Covance; Abcam), mouse anti-Rac1 (EMD Millipore), goat or rabbit anti-
PlexinD1 (R&D Systems; a gift from Y. Yoshida), and goat anti-SH3BP1 
(Everest Biotech Ltd.) overnight at 4°C. Cells were washed three times for 
additional 48 h in DMEM + 2% FBS. After 48 h, the media was collected 
and filtered to remove cell debris, and AP activity was measured. The AP-
Sema3E (delineated throughout manuscript as Sema3E) and AP (control li-
gand) were frozen at 80°C until use.
Plasmids and RNAi
A full-length human PlexinD1 (available from GenBank under accession 
no. NM_015103) was used to generate GFP-tagged constructs that were 
cloned into a pBK-CMV vector. For SH3BP1 HA fusion protein constructs, 
the sequences encoding the full-length mouse SH3BP1 (accession no. 
BC004598) were cloned into pCAG vector to produce a fusion protein. 
To generate the HA-tagged deletion constructs SH3BP1BAR (amino acids 
deleted:  2–174),  SH3BP1GAP  (amino  acids  deleted:  210–356),  or 
SH3BP1SH3 (amino acids deleted: 528–538), fusion protein constructs 
of the sequences without the indicated domains were cloned into a pCAG 
vector. To generate a mutant allele defective in GAP activity, arginine 
232 was replaced by an alanine residue using the mutagenesis kit (Quik-
Change; Agilent Technologies). The pGEX-KG-PAK-RBD vector encoding 
a GST-fused Rac-binding domain (RBD, amino acids 72–152) of mouse 
PAK-A was provided by K.-L. Guan (University of California San Diego, 
La Jolla, CA), pcDNA3 mammalian expression vector encoding human 
Rac1-Q61L was provided by M. Kirschner (Harvard Medical School, Boston, 
MA), and pAPtag-5-Sema3E vector encoding mouse Sema3E cloned in 
aAPtag-5  vector  was  obtained  from  F.  Mann  (Aix-Marseille  Université,   
Centre National de la Recherche Scientifique, Marseille, France). Empty 
pAPtag-5 vector (GenHunter) was used as a control. Sequences targeted in 
the siRNA screen were: PlexinD1, 5-GCAAGGAUUCGCCAACCAA-3; 
and SH3BP1, 5-GAUGACAGCCACCCACUUC-3.
Preparation of PAK GST fusion protein and Rac activity assay
The p21-activated protein kinase (PAK1) was expressed in bacteria as a 
GST fusion protein and coupled to agarose beads. The bacteria culture 
was grown until the OD at 600 nm reached 0.6–0.8. Transcription was in-
duced by the addition of 0.1 mM IPTG and bacteria were grown for 3 h 
at 30°C. The culture was centrifuged for 10 min at 2,300 g at 4°C. The 
pellet was washed once with cold PBS followed by centrifugation, resus-
pension in cold bacterial lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 5 mM MgCl2, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 1 µg/ml 
aprotinin), incubation on ice for 10 min, and sonication three times for   
30 s. The lysate was cleared by centrifugation (15 min, 20,000 g, 4°C). 
Sepharose 4B beads (GE Healthcare) were added to the supernatant and 
incubated for 2 h at 4°C on a rotator. Beads were washed five times with 
ice-cold bacterial lysis buffer, resuspended in washing buffer with 10% 
vol/vol glycerol (1:1 slurry), and stored at 80°C.
HUVECs treated with 2 nM Sema3E at 0, 10, and 20 min were 
washed rapidly with ice-cold PBS, then lysed in cell lysis buffer (50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 30 mM MgCl2, 1% NP-40, 1 mM DTT, 
protease inhibitor, and 2 mM sodium orthovanadate). The lysate was incu-
bated on ice for 15 min for efficient extraction, then vortexed and clarified 
by centrifugation for 10 min at 12,000 rpm and 4°C. Protein concentra-
tion was determined via the Bradford assay. After sample normalization, 
one-twentieth of the original sample was kept for immunoblotting to deter-
mine the total Rac1 content in the lysate. 10 µl of purified GST-PAK-RBD 
beads was added to the rest of each sample and incubated for 1 h at 4°C 
while rotating. The samples were centrifuged at 400 g for 2 min, the super-
natant was aspirated, and the pellet was washed three times in cell lysis 
buffer. Protein was eluted by the addition of 2× SDS-PAGE sample buffer 
and boiling for 5 min.
Rescue experiments
Reverse transfection with Dharmafect (Thermo Fisher Scientific) was used 
for delivering siRNAs into HUVECs. After 24 h, cells were transfected with 
the SH3BP1 and control (pCAG-GFP-HA) constructs using Lipofectamine 
2000 (Invitrogen). 24 h after the DNA transfection, cells were treated with 
2 nM Sema3E, fixed in 4% PFA, washed in 1× PBS, and stained with   
5-([4,6-Dichlorotriazin-2-yl]amino)fluorescein hydrochloride (DTAF) in 1× PBT 
(1× PBS + 0.1% Triton X-100) for 1 h. Then cells were washed three times 
in PBT, blocked in 3% BSA, and incubated with mouse anti-HA (Covance) 
primary antibody overnight at 4°C. Cells were washed three times for   
5 min in 1× PBS and incubated with Alexa Fluor 567 anti–mouse second-
ary antibodies for 1 h at room temperature. Coverslips were mounted on 
slides using ProLong Gold antifade reagent with DAPI (Life Technologies). 
Cells collapse was analyzed manually. A minimum of 50 cells were quanti-
fied for each condition.JCB • VOLUME 205 • NUMBER 4 • 2014   588
Imaging and image analysis
After immunostaining, plates were imaged using a high-content screening 
system (ImageXpress Micro; Molecular Devices) using a 10× 0.3 NA 
Plan Fluor objective lens and suitable filters (DAPI and Texas red for DiI). 
Four sites were imaged from each well. For image analysis, the images 
were preprocessed using CellProfiler. During the preprocessing, nuclei 
and whole cells are segmented using the DAPI and DiI channels, respec-
tively. The segmented cellular masks were then passed onto our custom-
developed  image  analysis  algorithm  in  MATLAB,  which  detects  the 
distinct membrane protrusions present on the cell surface of collapsed 
cells. The custom algorithm then combines the information of membrane 
protrusions with cellular area to classify individual cells into collapsed 
and intact populations. We also took into account the neighborhood en-
vironment of each cell by eliminating all the cells that are completely sur-
rounded by their neighboring cells from the analysis. The percentage of 
cells that are classified as collapsed is computed for each well, and is 
used as the metric to identify the potential hits in the screen. The total cell 
numbers counted for each condition are as follows. Fig. 1 C: nontarget-
ing siRNA control ligand treatment, 20,624; nontargeting siRNA Sema3E 
treatment, 25,365; PlexinD1 siRNA control ligand treatment, 2,684; and 
PlexinD1 siRNA Sema3E treatment, 1,887. Fig. 3 B: no siRNA, 18,850; 
nontargeting siRNA, 9,996; PlexinD1 siRNA, 7,197; and SH3BP1, 833. 
The Z score is 0.32. The large-scale image analysis was performed on 
the Orchestra high-performance computing cluster at the Harvard Medi-
cal School.
Statistical analysis
The SEM or SD of the mean was calculated from the mean of at least three 
independent experiments. Bars in the graph of the screen data represent 
SD. In the rest of the graphs, SEM is provided. Respective n values are pro-
vided in the figure legends. The indicated P-values were obtained with the 
two-tailed Student’s t test.
Online supplemental material
Fig. S1 shows that endogenous PlexinD1 expression in HUVECs could be 
down-regulated by specific PlexinD1 siRNA and used as a positive control 
in the screen. Fig. S2 shows the expression of SH3BP1 and the specificity 
of SH3BP1 siRNA. Fig. S3 shows Sema3E-regulated cytoskeleton changes. 
Fig. S4 shows that Rac1 is regulated by Sema3E. Fig. S5 shows that 
SH3BP1BAR did not colocalize with PlexinD1 in the lamellipodia. Video 
1  shows  that  control  siRNA–transfected  cells  underwent  morphological 
changes and exhibited cell collapse in response to Sema3E treatment. 
Video 2 shows that PlexinD1 siRNA-transfected cells did not display any 
morphological changes after Sema3E treatment. Video 3 shows that SH3BP1 
siRNA-transfected cells did not display any morphological changes after 
Sema3E treatment. Table S1 shows exemplar genes demonstrating Sema3E-
induced hypercollapse after gene down-regulation. Table S2 shows a list of 
genes identified in the secondary screen. A custom MATLAB algorithm is 
provided as raw code in a TXT file. This program processes the images 
after they have been segmented by CellProfiler, analyzes the protrusions of 
each cell by shrinking the cells and comparing with the original one, mea-
sures object properties, and merges sections that belong to the same cell 
back together. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201309004/DC1.
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5 min in 1× PBS and incubated with Alexa Fluor 488 anti–rabbit and 
Alexa Fluor 567 anti–mouse secondary antibodies for 1 h at room temper-
ature. Coverslips were mounted on slides using ProLong Gold antifade re-
agent with DAPI (Life Technologies). Cells used for colocalization studies 
were counted manually.
Actin staining
HUVECs were grown on coverslips and then transfected with control, PlexinD1, 
or SH3BP1 siRNA. 48 h after transfection, cells were treated with Sema3E, 
rapidly washed with PBS, fixed in 4% PFA for 15 min, washed twice for 
5 min in PBS, and permeabilized for 10 min in 1× PBT (1× PBS + 0.1% Triton 
X-100). Cells were incubated with phalloidin Alexa Fluor 488 (Invitrogen) 
for 30 min at room temperature then washed five times for 5 min in PBS 
and mounted on slides. The presence of lamellipodia and actin stress fibers 
was counted manually in a minimum of 50 cells.
Live imaging
HUVEC were grown on glass-bottom culture dishes (MatTek Corporation) 
overnight. DIC images were acquired at intervals of 10 s with a micro-
scope (VivaView). First baseline images were acquired for 5–10 min, then 
cells were treated with AP-Sema3E ligand at a concentration of 2 nM, and 
images were acquired for the next 20 min. Cell size changes were ana-
lyzed in ImageJ. 7–12 cells were quantified for each condition.
Microscopy
All epifluorescent images of fixed specimens were acquired with a fluores-
cence microscope (Eclipse 80i; Nikon) using a 20×/0.75 NA or 60×/1.4 
NA oil immersion objective lens fitted with a digital camera (DS-2; Nikon) 
and  NIS-Elements  BR  3.0  software  (Nikon).  Images  were  adjusted  for 
brightness and contrast using ImageJ. Images from endothelial repulsion 
assays  were  acquired  with  an  inverted  florescent  microscope  (Eclipse 
TE2000-S; Nikon) using a 4×/0.2 NA objective lens, a digital camera 
(DS-5M; Nikon), and NIS-Elements BR 3.0 software (Nikon). Images were 
adjusted for brightness and contrast using ImageJ. Time-lapse videos were 
recorded at 37°C using an incubator live cell imaging microscope (VivaView 
FL LCV-110; Olympus) with a UPlan-SApochromat 40×/0.95 NA, WD 
0.18 mm objective lens (Olympus) and a camera (Orca R2 CCD; Hama-
matsu Photonics). Videos were acquired with MetaMorph for Olympus   
VivaView FL LCV-110 software, and separated images were adjusted   
for brightness and contrast using ImageJ.
Screen protocol
An RNAi library composed of 21,121 smart pools of four siRNA oligos, 
each targeting the whole human genome (siARRAY siRNA Library, human 
genome, G-005000-05; Thermo Fisher Scientific) was used. For the sec-
ondary screen, individual siRNA oligos from the pool in the primary screen 
were assayed. Reverse transfection with Dharmafect (Thermo Fisher Scien-
tific) was used for delivering siRNAs into HUVECs in triplicate in a 384-well 
plate format.
Reverse transfection
A 384-well assay plate was loaded with 2 µl of 1 µM siRNA using the Veloc-
ity11 Bravo robot inside a biological safety cabinet (Bioprotect II; Baker). 
Each well of the 384-well plates contained a smart pool of four siRNA oligos 
targeting a single gene or a control siRNA. Then 6 µl of Opti-MEM media 
and Dharmafect No. 1 transfection reagent mixed at a ratio of 1:300 were 
added using an automated solution dispenser (WellMate; Matrix). Samples 
were spun down to ensure proper mixing and incubated at room tempera-
ture for 20 min to allow lipid siRNA complexes to form. Finally, HUVECs 
were plated at a density of 280 cells/well in 32 µl of media to bring the 
total reaction volume to 40 µl per well and the siRNA concentration to 50 nM. 
The final concentration of 50 nM is optimized to provide effective mRNA 
knockdown while avoiding off-target effects. Assay plates were run so that 
each library plate was treated with Sema3E in duplicate.
Ligand treatment and Dil staining
48 h after transfection, cells in the screening plates were treated with either 
Sema3E or control ligand. Plates were removed from the incubator and so-
lution was aspirated using a microplate washer (ELx405; BioTek) until 25 µl 
remained. Using the automated solution dispenser (Wellmate; Matrix),   
25 µl of 4 nM Sema3E or control ligand was added for a final concentra-
tion of 2 nM. The plates were then returned to the incubator for 25 min. 
After ligand treatment, cells were fixed using 4% PFA and stained with 
0.003% DiI in 50% ethanol for 10 min and DAPI (0.5 µg/ml) for 5 min. All 
fixation and staining steps were done with high-throughput automation ac-
complished using the Wellmate and the ELx405 microplate washer.589 SH3BP1 mediates Sema3E-PlexinD1 signaling • Tata et al.
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